APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Cirrhosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liver Cirrhosis Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchLiver Cirrhosis Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Cirrhosis Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Liver Cirrhosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Cirrhosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Cirrhosis Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Liver Cirrhosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liver Cirrhosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liver Cirrhosis market include Johnson & Johnson, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Intercept Pharmaceuticals, Instituto Grifols, Gwo Xi Stem Cell Applied Technology, Gilead Sciences and F Hoffman La-Roche, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Liver Cirrhosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liver Cirrhosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liver Cirrhosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Liver Cirrhosis market.

Liver Cirrhosis Segment by Company

Johnson & Johnson

Merck

GlaxoSmithKline

Bristol-Myers Squibb

Intercept Pharmaceuticals

Instituto Grifols

Gwo Xi Stem Cell Applied Technology

Gilead Sciences

F Hoffman La-Roche

Conatus Pharmaceuticals

Liver Cirrhosis Segment by Type

Cryptogenic Cirrhosis

Cardiac Cirrhosis

Atrophic Cirrhosis

Alcoholic Cirrhosis

Biliary Cirrhosis

Liver Cirrhosis Segment by Application

Hospitals

Specialty Clinics

Liver Cirrhosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liver Cirrhosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Liver Cirrhosis key companies, revenue, market share, and recent developments.

3. To split the Liver Cirrhosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Liver Cirrhosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liver Cirrhosis significant trends, drivers, influence factors in global and regions.

6. To analyze Liver Cirrhosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liver Cirrhosis industry.

Chapter 3: Detailed analysis of Liver Cirrhosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Liver Cirrhosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Liver Cirrhosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liver Cirrhosis Industry Trends Table 2. Liver Cirrhosis Industry Drivers Table 3. Liver Cirrhosis Industry Opportunities and Challenges Table 4. Liver Cirrhosis Industry Restraints Table 5. Global Liver Cirrhosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liver Cirrhosis Revenue Share by Company (2021-2026) Table 7. Global Liver Cirrhosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Liver Cirrhosis Key Company Manufacturing Base & Headquarters Table 9. Global Liver Cirrhosis Company, Product Type & Application Table 10. Global Liver Cirrhosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Liver Cirrhosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cryptogenic Cirrhosis Table 15. Significant Companies of Cardiac Cirrhosis Table 16. Significant Companies of Atrophic Cirrhosis Table 17. Significant Companies of Alcoholic Cirrhosis Table 18. Significant Companies of Biliary Cirrhosis Table 19. Global Liver Cirrhosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Liver Cirrhosis Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Liver Cirrhosis Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Liver Cirrhosis Sales Value Share by Type (2021-2026) Table 23. Global Liver Cirrhosis Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Specialty Clinics Table 26. Global Liver Cirrhosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Liver Cirrhosis Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Liver Cirrhosis Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Liver Cirrhosis Sales Value Share by Application (2021-2026) Table 30. Global Liver Cirrhosis Sales Value Share by Application (2027-2032) Table 31. Global Liver Cirrhosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Liver Cirrhosis Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Liver Cirrhosis Sales Value Share by Region (2021-2026) Table 34. Global Liver Cirrhosis Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Liver Cirrhosis Sales Value Share by Region (2027-2032) Table 36. Global Liver Cirrhosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Liver Cirrhosis Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Liver Cirrhosis Sales Value Market Share by Country (2021-2026) Table 39. Global Liver Cirrhosis Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Liver Cirrhosis Sales Value Market Share by Country (2027-2032) Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Johnson & Johnson Liver Cirrhosis Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Merck Company Information Table 47. Merck Business Overview Table 48. Merck Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Merck Liver Cirrhosis Product Portfolio Table 50. Merck Recent Development Table 51. GlaxoSmithKline Company Information Table 52. GlaxoSmithKline Business Overview Table 53. GlaxoSmithKline Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. GlaxoSmithKline Liver Cirrhosis Product Portfolio Table 55. GlaxoSmithKline Recent Development Table 56. Bristol-Myers Squibb Company Information Table 57. Bristol-Myers Squibb Business Overview Table 58. Bristol-Myers Squibb Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bristol-Myers Squibb Liver Cirrhosis Product Portfolio Table 60. Bristol-Myers Squibb Recent Development Table 61. Intercept Pharmaceuticals Company Information Table 62. Intercept Pharmaceuticals Business Overview Table 63. Intercept Pharmaceuticals Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio Table 65. Intercept Pharmaceuticals Recent Development Table 66. Instituto Grifols Company Information Table 67. Instituto Grifols Business Overview Table 68. Instituto Grifols Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Instituto Grifols Liver Cirrhosis Product Portfolio Table 70. Instituto Grifols Recent Development Table 71. Gwo Xi Stem Cell Applied Technology Company Information Table 72. Gwo Xi Stem Cell Applied Technology Business Overview Table 73. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio Table 75. Gwo Xi Stem Cell Applied Technology Recent Development Table 76. Gilead Sciences Company Information Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Gilead Sciences Liver Cirrhosis Product Portfolio Table 80. Gilead Sciences Recent Development Table 81. F Hoffman La-Roche Company Information Table 82. F Hoffman La-Roche Business Overview Table 83. F Hoffman La-Roche Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. F Hoffman La-Roche Liver Cirrhosis Product Portfolio Table 85. F Hoffman La-Roche Recent Development Table 86. Conatus Pharmaceuticals Company Information Table 87. Conatus Pharmaceuticals Business Overview Table 88. Conatus Pharmaceuticals Liver Cirrhosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio Table 90. Conatus Pharmaceuticals Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Liver Cirrhosis Product Image Figure 2. Global Liver Cirrhosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Cirrhosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Liver Cirrhosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cryptogenic Cirrhosis Image Figure 8. Cardiac Cirrhosis Image Figure 9. Atrophic Cirrhosis Image Figure 10. Alcoholic Cirrhosis Image Figure 11. Biliary Cirrhosis Image Figure 12. Global Liver Cirrhosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Liver Cirrhosis Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Liver Cirrhosis Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Specialty Clinics Image Figure 17. Global Liver Cirrhosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Liver Cirrhosis Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Liver Cirrhosis Sales Value Share by Application (2021-2032) Figure 20. Global Liver Cirrhosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Liver Cirrhosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Liver Cirrhosis Sales Value (2021-2032) & (US$ Million) Figure 23. North America Liver Cirrhosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Liver Cirrhosis Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Liver Cirrhosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Liver Cirrhosis Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Liver Cirrhosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Liver Cirrhosis Sales Value (2021-2032) & (US$ Million) Figure 29. South America Liver Cirrhosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Liver Cirrhosis Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Liver Cirrhosis Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Liver Cirrhosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cryptogenic Cirrhosis
  • Cardiac Cirrhosis
  • Atrophic Cirrhosis
  • Alcoholic Cirrhosis
  • Biliary Cirrhosis
Applications
  • Hospitals
  • Specialty Clinics
Companies covered
  • Johnson & Johnson
  • Merck
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Intercept Pharmaceuticals
  • Instituto Grifols
  • Gwo Xi Stem Cell Applied Technology
  • Gilead Sciences
  • F Hoffman La-Roche
  • Conatus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liver Cirrhosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liver Cirrhosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Liver Cirrhosis Market Dynamics
  1. 2.1 Liver Cirrhosis Industry Trends
  2. 2.2 Liver Cirrhosis Industry Drivers
  3. 2.3 Liver Cirrhosis Industry Opportunities and Challenges
  4. 2.4 Liver Cirrhosis Industry Restraints
3 Liver Cirrhosis Market by Company
  1. 3.1 Global Liver Cirrhosis Company Revenue Ranking in 2025
  2. 3.2 Global Liver Cirrhosis Revenue by Company (2021-2026)
  3. 3.3 Global Liver Cirrhosis Company Ranking (2024-2026)
  4. 3.4 Global Liver Cirrhosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Liver Cirrhosis Company Product Type and Application
  6. 3.6 Global Liver Cirrhosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Liver Cirrhosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Liver Cirrhosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Liver Cirrhosis Market by Type
  1. 4.1 Liver Cirrhosis Type Introduction
  2. 4.1.1 Cryptogenic Cirrhosis
  3. 4.1.2 Cardiac Cirrhosis
  4. 4.1.3 Atrophic Cirrhosis
  5. 4.1.4 Alcoholic Cirrhosis
  6. 4.1.5 Biliary Cirrhosis
  7. 4.2 Global Liver Cirrhosis Sales Value by Type
  8. 4.2.1 Global Liver Cirrhosis Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Liver Cirrhosis Sales Value by Type (2021-2032)
  10. 4.2.3 Global Liver Cirrhosis Sales Value Share by Type (2021-2032)
5 Liver Cirrhosis Market by Application
  1. 5.1 Liver Cirrhosis Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Specialty Clinics
  4. 5.2 Global Liver Cirrhosis Sales Value by Application
  5. 5.2.1 Global Liver Cirrhosis Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Liver Cirrhosis Sales Value by Application (2021-2032)
  7. 5.2.3 Global Liver Cirrhosis Sales Value Share by Application (2021-2032)
6 Liver Cirrhosis Regional Value Analysis
  1. 6.1 Global Liver Cirrhosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liver Cirrhosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Liver Cirrhosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Liver Cirrhosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liver Cirrhosis Sales Value (2021-2032)
  7. 6.3.2 North America Liver Cirrhosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Liver Cirrhosis Sales Value (2021-2032)
  10. 6.4.2 Europe Liver Cirrhosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Liver Cirrhosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Liver Cirrhosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Liver Cirrhosis Sales Value (2021-2032)
  16. 6.6.2 South America Liver Cirrhosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Liver Cirrhosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Liver Cirrhosis Sales Value Share by Country, 2025 VS 2032
7 Liver Cirrhosis Country-level Value Analysis
  1. 7.1 Global Liver Cirrhosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liver Cirrhosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Liver Cirrhosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Liver Cirrhosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Liver Cirrhosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Liver Cirrhosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Liver Cirrhosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Liver Cirrhosis Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Liver Cirrhosis Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Liver Cirrhosis Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Liver Cirrhosis Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 Intercept Pharmaceuticals
  26. 8.5.1 Intercept Pharmaceuticals Company Information
  27. 8.5.2 Intercept Pharmaceuticals Business Overview
  28. 8.5.3 Intercept Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio
  30. 8.5.5 Intercept Pharmaceuticals Recent Developments
  31. 8.6 Instituto Grifols
  32. 8.6.1 Instituto Grifols Company Information
  33. 8.6.2 Instituto Grifols Business Overview
  34. 8.6.3 Instituto Grifols Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Instituto Grifols Liver Cirrhosis Product Portfolio
  36. 8.6.5 Instituto Grifols Recent Developments
  37. 8.7 Gwo Xi Stem Cell Applied Technology
  38. 8.7.1 Gwo Xi Stem Cell Applied Technology Company Information
  39. 8.7.2 Gwo Xi Stem Cell Applied Technology Business Overview
  40. 8.7.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio
  42. 8.7.5 Gwo Xi Stem Cell Applied Technology Recent Developments
  43. 8.8 Gilead Sciences
  44. 8.8.1 Gilead Sciences Company Information
  45. 8.8.2 Gilead Sciences Business Overview
  46. 8.8.3 Gilead Sciences Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gilead Sciences Liver Cirrhosis Product Portfolio
  48. 8.8.5 Gilead Sciences Recent Developments
  49. 8.9 F Hoffman La-Roche
  50. 8.9.1 F Hoffman La-Roche Company Information
  51. 8.9.2 F Hoffman La-Roche Business Overview
  52. 8.9.3 F Hoffman La-Roche Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 F Hoffman La-Roche Liver Cirrhosis Product Portfolio
  54. 8.9.5 F Hoffman La-Roche Recent Developments
  55. 8.10 Conatus Pharmaceuticals
  56. 8.10.1 Conatus Pharmaceuticals Company Information
  57. 8.10.2 Conatus Pharmaceuticals Business Overview
  58. 8.10.3 Conatus Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio
  60. 8.10.5 Conatus Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst